Publication | Closed Access

Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways

OncologyMedicineReceptor Tyrosine KinaseCancer BiologyDownstream Erk1/2Akt PathwaysAnti-tumor ActivityPharmacologyCell BiologyCancer ResearchTumor Biology